Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma
Status:
NOT_YET_RECRUITING
Trial end date:
2027-09-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the efficacy and safety of aspirin and rivaroxaban in thromboprophylaxis in Chinese MM patients at high risk for MM-associated VTE.
Phase:
PHASE3
Details
Lead Sponsor:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology